Market Insights Health Hospitals Inpatient Care

Treatment of Cardiovascular Diseases - Americas

Americas

In the Americas, the Treatment of Cardiovascular Diseases market is anticipated to witness significant growth in the coming years.
According to projections, the market's revenue is expected to reach a staggering US$170.00bn by 2024.
Furthermore, it is estimated that the market will experience a compound annual growth rate (CAGR) of 3.56% from 2024 to 2029, resulting in a market volume of US$202.50bn by the end of the forecast period.
When considering the global landscape, United States is expected to be the leading revenue generator, with an estimated revenue of US$136.00bn in 2024.
This highlights the significant contribution of the United States to the overall market.
In the United States, there is a rising trend towards utilizing telemedicine for remote monitoring and management of cardiovascular diseases.

Key regions: Germany, France, Japan, Europe, India

Market

Region

Region comparison

Currency

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on revenue received by hospitals from public or private sources, allocated to the country where the money is spent, including VAT if applicable.

Modeling approach / Market size:

Market sizes are determined by a bottom-up approach, based on a specific rationale for each market market. Next, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, public health spend, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.